• Users Online: 169
  • Print this page
  • Email this page

    Article Cited by others

REVIEW ARTICLE

Repurposing valproate to prevent acute respiratory distress syndrome/acute lung injury in COVID-19: A review of immunomodulatory action

Bhargava Prabhat, Panda Pankaj, Ostwal Vikas, Ramaswamy Anant

Year : 2020| Volume: 3| Issue : 5 | Page no: 65-70

   This article has been cited by
 
1 Clozapine, neutropenia and Covid-19: should clinicians be concerned? 3 months report
Stefania Bonaccorso,Angelo Ricciardi,Sophie Ouabbou,Christos Theleritis,Arabella Ross-Michealides,Antonio Metastasio,Neil Stewart,Marwa Mohammed,Fabrizio Schifano
Brain, Behavior, & Immunity - Health. 2021; : 100212
[Pubmed]  [Google Scholar] [DOI]
2 Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model
Tingxuan Gu,Simin Zhao,Guoguo Jin,Mengqiu Song,Yafei Zhi,Ran Zhao,Fayang Ma,Yaqiu Zheng,Keke Wang,Hui Liu,Mingxia Xin,Wei Han,Xiang Li,Christopher D. Dong,Kangdong Liu,Zigang Dong
Frontiers in Immunology. 2021; 11
[Pubmed]  [Google Scholar] [DOI]
3 Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19
Bertram Pitt,Nadia R. Sutton,Zhong Wang,Sascha N. Goonewardena,Michael Holinstat
European Journal of Pharmacology. 2021; : 173988
[Pubmed]  [Google Scholar] [DOI]
4 Cytokine Profile and Disease Severity in Patients with COVID-19
Ali Ghazavi,Ali Ganji,Nafiseh Keshavarzian,Somayeh Rabiemajd,Ghasem Mosayebi
Cytokine. 2020; : 155323
[Pubmed]  [Google Scholar] [DOI]
5 A connectivity map-based drug repurposing study and integrative analysis of transcriptomic profiling of SARS-CoV-2 infection
Seyedeh Zahra Mousavi,Mojdeh Rahmanian,Ashkan Sami
Infection, Genetics and Evolution. 2020; 86: 104610
[Pubmed]  [Google Scholar] [DOI]
6 Immunopharmacological management of COVID-19: Potential therapeutic role of valproic acid
Gokhan Unal,Bahadir Turan,Yasin Hasan Balcioglu
Medical Hypotheses. 2020; 143: 109891
[Pubmed]  [Google Scholar] [DOI]

 

Read this article